| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.003 | 1.403 | 2.836 | 5.503 | 5.658 | 5.292 | 10.997 | 9.460 | 5.135 | 4.202 |
| Total Income - EUR | 2.003 | 1.403 | 2.836 | 5.503 | 5.658 | 5.292 | 10.997 | 9.460 | 5.135 | 4.202 |
| Total Expenses - EUR | 2.350 | 2.708 | 5.230 | 5.215 | 4.710 | 4.686 | 4.357 | 5.924 | 5.151 | 6.906 |
| Gross Profit/Loss - EUR | -347 | -1.305 | -2.394 | 288 | 948 | 607 | 6.640 | 3.536 | -16 | -2.704 |
| Net Profit/Loss - EUR | -407 | -1.347 | -2.480 | 133 | 778 | 448 | 6.310 | 3.257 | -16 | -2.704 |
| Employees | 3 | 3 | 3 | 4 | 3 | 2 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Medicinart Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 35.708 | 35.343 | 34.745 | 872 | 749 | 638 | 522 | 420 | 328 | 242 |
| Current Assets | 181 | 63 | 166 | 344 | 1.257 | 366 | 6.285 | 5.541 | 2.641 | 1.182 |
| Inventories | 149 | 0 | 63 | 0 | 0 | 0 | 517 | 0 | 0 | 0 |
| Receivables | 48 | 47 | 53 | 3 | 8 | 82 | 81 | 17 | 101 | 100 |
| Cash | -16 | 16 | 51 | 341 | 1.249 | 283 | 5.687 | 5.523 | 2.541 | 1.082 |
| Shareholders Funds | 30.461 | 28.803 | 25.836 | -8.612 | -7.668 | -7.075 | -608 | 2.648 | 1.668 | -1.046 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.698 | 6.603 | 9.075 | 9.829 | 9.673 | 8.079 | 7.414 | 3.313 | 1.301 | 2.470 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8512 - 8512" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medicinart Srl